Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 2/20 | 0.35 |
| ▸ | CCR2 | P41597 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16882811 | 0.86 | CHRNB2 (0.46) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL1711553 | 0.86 | CHRNB2 (0.46) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL928271 | 0.86 | CHRNB2 (0.46) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL1711225 | 0.86 | CHRNB2 (0.46) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL13964499 | 0.83 | CHRM2 (0.51) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL12842007 | 0.83 | CHRM2 (0.51) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL12526945 | 0.83 | CHRM2 (0.51) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL19583627 | 0.81 | CHRM2 (0.47) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL30576874 | 0.81 | CHRM2 (0.43) | CHRM2CHRM1CHRM3HSD11B1NR1H2 | |
| SCHEMBL27043844 | 0.81 | CHRM2 (0.43) | CHRM2CHRM1CHRM3HSD11B1NR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023192989-A2 | PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS | AZKARRA THERAPEUTICS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| EP-4223761-A1 | QUINAZOLINE COMPOUND AND APPLICATION THEREOF | Shanghai Pharmaceuticals Holding Co., Ltd. (CN) | 2023-08-09 | — | — | EP | disclosed |
| WO-2023039240-A9 | IRREVERSIBLE INHIBITORS OF KRas | BIOMEA FUSION, INC. (US) | 2023-06-01 | — | — | WO | disclosed |
| WO-2023061463-A1 | NOVEL PYRIMIDOPYRIDINE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | 广东东阳光药业有限公司 | 2023-04-20 | — | — | WO | disclosed |
| WO-2021041671-A1 | KRAS G12D INHIBITORS | Mirati Therapeutics, Inc. (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-2704720-B1 | PYRUVATE KINASE R ACTIVATORS FOR USE IN THERAPY | AGIOS PHARMACEUTICALS INC (US) | 2019-08-07 | — | — | EP | disclosed |
| WO-2018089433-A1 | PHENYL mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |